Lupin Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Lupin announced that the 44th Annual General Meeting(AGM) of the company will be held on 4 August 2026.

Lupin has allotted 2,358 equity shares under ESOP on 08 July 2026. With this allotment, the paid up equity share capital has increased to Rs 91,44,69,788 consisting of 45,72,34,894 equity shares of Rs 2/- each.

Lupin has fixed 17 July 2026 as record date for final dividend of Rs 18 per equity share for FY 2026.

Lupin today announced that the European Medicines Agency (EMA) has approved a change to the terms of marketing authorization for NaMuscla, supported by the Pediatric Investigation Plan (PIP). The approval includes two new dosage strengths, 62 mg and 83 mg capsules, in addition to the existing 167 mg, and the revised indications that cover symptomatic treatment of myotonia in children (6?C11 years, weighing at least 20 kg), adolescents (12?C17 years), and adults (??18 years) with non-dystrophic myotonic disorder.